cagrilintide peptide with tirzepatide Dosage Tirzepatide: Dual Combo Guide Cagrilintide + GLP-1 T (1+10mg)

Launch now or wait

Frequent or severe vomiting is not normal and should be reported immediately

Figure 3F)

Contact your healthcare provider immediately if you experience: Severe, persistent abdominal pain (could indicate pancreatitis, gallbladder disease, or surgical complications) Persistent vomiting preventing fluid intake (risk of dehydration and acute kidney injury) Signs of dehydration (dark urine, dizziness, reduced urination) Symptoms of hypoglycaemia if taking other diabetes medications Unusual fatigue, fever, or wound-related concerns The Ozempic SmPC specifically mentions pancreatitis and gallbladder disease as potential risks that require prompt medical attention